Literature DB >> 20716835

Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system.

Keiichi Kamijo1.   

Abstract

The purposes of this study are to set the Elecsys TRAb cutoff value by which GD and PT can be accurately diagnosed simply; and to investigate the usefulness of the vascularity index (VI) obtained from power Doppler sonography (PDS). Using 109 normal controls, 186 GD patients, and 109 PT patients who were diagnosed through Tc-99m uptake, we set the cutoff value by conducting ROC analysis on the Elecsys TRAb values. The cutoff value as a result of the ROC analysis on the Elecsys TRAb values of the normal controls and GD patients was 0.8 IU/L with 100% of sensitivity and specificity. Because all 89 cases (81.6% of the entire PT cases) with Elecsys TRAb =<0.8 IU/L are PT, the cutoff =<0.8IU/L can thus be diagnosed as PT. In contrast, because all 166 cases (88.7% of the entire GD) with Elecsys TRAb >=3.0 IU/L except for one case of PT are GD, the cutoff >=3.0 IU/L can be diagnosed as GD. So Elecsys TRAb between 0.8-3.0 IU/L was dubbed gray zone (GZ). Finally, the cutoff value of 1.5 IU/L from the ROC on the PT and GD cases was chosen as the cutoff with 96.2% of sensitivity and 94.6 of specificity. All PDS VI >=80% were GD including 4 of 6 cases with GZ and all PDS VI <50% plus Elecsys TRAb-negative cases were PT including 4 of 5 cases with GZ. In conclusion, Elecsys TRAb cutoff and VI value for differential diagnosis between GD and PT has been set successfully.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716835     DOI: 10.1507/endocrj.k10e-199

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  9 in total

1.  Diagnosis of pediatric hyperthyroidism: technetium 99 uptake versus thyroid stimulating immunoglobulins.

Authors:  Charumathi Baskaran; Madhusmita Misra; Lynne L Levitsky
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

2.  Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters.

Authors:  Zhaowei Meng; Guizhi Zhang; Haoran Sun; Jian Tan; Chunshun Yu; Weijun Tian; Weidong Li; Zhiqiang Yang; Mei Zhu; Qing He; Yujie Zhang; Shugao Han
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

3.  Thyrotropin receptor antibody immunoassays may not be reliable in confirming diagnosis of Painless Thyroiditis.

Authors:  D Sanyal; S Chatterjee
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

4.  Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016.

Authors:  Kanshi Minamitani; Hirokazu Sato; Hidemi Ohye; Shohei Harada; Osamu Arisaka
Journal:  Clin Pediatr Endocrinol       Date:  2017-04-22

5.  Role of Diffusion-Weighted Magnetic Resonance (MR) Imaging in Differentiation Between Graves' Disease and Painless Thyroiditis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sieza Samir Abd Allah; Amr Abd El-Hamid El-Said
Journal:  Pol J Radiol       Date:  2017-09-15

6.  Painless Thyroiditis with Thyrotropin Receptor-blocking and Receptor-stimulating Autoantibodies.

Authors:  Keiichi Kamijo
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

7.  Hemodynamic Changes in the Masseter and Superior Orbicularis Oris Muscles before and after Exercise Load: A Comparison between Young Adult Women and Middle-Aged to Old Adult Women.

Authors:  Keiko Okamoto; Chihiro Tanikawa; Kenji Takada
Journal:  Int J Dent       Date:  2022-08-27

8.  Autoimmunity and pulmonary hypertension in patients with Graves' disease.

Authors:  Tetsuro Sugiura; Shigeo Yamanaka; Hiroaki Takeuchi; Norihito Morimoto; Mikio Kamioka; Yoshihisa Matsumura
Journal:  Heart Vessels       Date:  2014-05-18       Impact factor: 2.037

9.  The Association of Autoantibodies in Hyperthyroid Heart Disease Combined with Pulmonary Hypertension.

Authors:  Xiujuan Zhang; Lin Chen; Jianping Sheng; Chaoying Li; Yong He; WenXia Han
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.